BDBM62531 MLS000075125::N-(5-Phenylacetylamino-pyridin-2-yl)-propionamide::N-[5-(2-phenylethanoylamino)pyridin-2-yl]propanamide::N-[5-[(1-oxo-2-phenylethyl)amino]-2-pyridinyl]propanamide::N-[5-[(2-phenylacetyl)amino]-2-pyridyl]propionamide::N-[5-[(2-phenylacetyl)amino]pyridin-2-yl]propanamide::SMR000005477::cid_646148

SMILES COC(=O)Cn1nc2cc(N3CCOc4cc(C(=O)N5CCCCC5)cnc43)ccn2c1=O

InChI Key InChIKey=NHOIYJYMKIWEPK-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62531   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62531BDBM62531(US12577217, Example 1-40)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent